相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。TMPRSS2 fusions with oncogenic ETS factors in prostate cancer involve unbalanced genomic rearrangements and are associated with HDAC1 and epigenetic reprogramming
Kristiina Iljin et al.
CANCER RESEARCH (2006)
Histone deacetylase 3 (HDAC3) and other class IHDACs regulate colon cell maturation and p21 expression and are deregulated in human colon cancer
AJ Wilson et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Sulforaphane inhibits histone deacetylase activity in BPH-1, LnCaP and PC-3 prostate epithelial cells
MC Myzak et al.
CARCINOGENESIS (2006)
How well does the gleason score predict prostate cancer death?: A 20-year followup of a population based cohort in Sweden
O Andrén et al.
JOURNAL OF UROLOGY (2006)
The application of epigenetic modifiers on the treatment of prostate and bladder cancer
ZW Zhang et al.
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS (2006)
Targeting tumor angiogenesis with histone deacetylase inhibitors: the hydroxamic acid derivative LBH589
DZ Qian et al.
CLINICAL CANCER RESEARCH (2006)
Epigenetic therapy of cancer: past, present and future
CB Yoo et al.
NATURE REVIEWS DRUG DISCOVERY (2006)
Histone deacetylase inhibitors and the promise of epigenetic (and more) treatments for cancer
S Minucci et al.
NATURE REVIEWS CANCER (2006)
Differentiation of androgen-independent prostate cancer PC-3 cells is associated with increased nuclear factor-κB activity
D Floryk et al.
CANCER RESEARCH (2005)
Histone deacetylase inhibitors induce differentiation of human endometrial adenocarcinoma cells through up-regulation of glycodelin
H Uchida et al.
ENDOCRINOLOGY (2005)
A new simple and high-yield synthesis of suberoylanilide hydroxamic acid and its inhibitory effect alone or in combination with retinoids on proliferation of human prostate cancer cells
LK Gediya et al.
JOURNAL OF MEDICINAL CHEMISTRY (2005)
Evolving anticancer drug valproic acid: Insights into the mechanism and clinical studies
RA Blaheta et al.
MEDICINAL RESEARCH REVIEWS (2005)
Depsipeptide inhibits migration of primary and metastatic uveal melanoma cell lines in vitro:: a potential strategy for uveal melanoma
DD Klisovic et al.
MELANOMA RESEARCH (2005)
Histone deacetylase inhibitors differentially stabilize acetylated p53 and induce cell cycle arrest or apoptosis in prostate cancer cells
S Roy et al.
CELL DEATH AND DIFFERENTIATION (2005)
Modulation of radiation response by histone deacetylase inhibition
P Chinnaiyan et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2005)
Histone deacetylase-1 and-3 protein expression in human breast cancer:: a tissue microarray analysis
CA Krusche et al.
BREAST CANCER RESEARCH AND TREATMENT (2005)
Histone deacetylase inhibitors differentially mediate apoptosis in prostate cancer cells
K Fronsdal et al.
PROSTATE (2005)
Loss of Gelsolin expression in human ovarian carcinomas
A Noske et al.
EUROPEAN JOURNAL OF CANCER (2005)
Upregulation and nuclear recruitment of HDACI in hormone refractory prostate cancer
K Halkidou et al.
PROSTATE (2004)
Apicidin is a histone deacetylase inhibitor with anti-invasive and anti-angiogenic potentials
SH Kim et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2004)
Sodium butyrate and tributyrin induce in vivo growth inhibition and apoptosis in human prostate cancer
R Kuefer et al.
BRITISH JOURNAL OF CANCER (2004)
Histone deacetylase inhibitors have a profound antigrowth activity in endometrial cancer cells
N Takai et al.
CLINICAL CANCER RESEARCH (2004)
Human ovarian carcinoma cells: Histone deacetylase inhibitors exhibit antiproliferative activity and potently induce apoptosis
N Takai et al.
CANCER (2004)
Inhibition of hypoxia-induced angiogenesis by FK228, a specific histone deacetylase inhibitor, via suppression of HIF-1α activity
YM Lee et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2003)
Actin filament formation, reorganization and migration are impaired in hepatic stellate cells under influence of trichostatin A, a histone deacetylase inhibitor
K Rombouts et al.
JOURNAL OF HEPATOLOGY (2002)
Histone deacetylase inhibitor FK228 inhibits tumor angiogenesis
HJ Kwon et al.
INTERNATIONAL JOURNAL OF CANCER (2002)
Histone deacetylases induce angiogenesis by negative regulation of tumor suppressor genes
MS Kim et al.
NATURE MEDICINE (2001)
Histone deacetylase inhibitors: Development of suberoylanilide hydroxamic acid (SAHA) for the treatment of cancers
VM Richon et al.
BLOOD CELLS MOLECULES AND DISEASES (2001)
分享论文
